Marta Hájková

The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis

Tanja Tran, Martina Šterclová, Nesrin Moğulkoç et al. · Respiratory Research · 2020 · 68 citations · Full text

Public Health, Biostatistics, Epidemiology +12

Comorbidity burden and survival in patients with idiopathic pulmonary fibrosis: the EMPIRE registry study

Dragana Jovanović, Martina Šterclová, Nesrin Moğulkoç et al. · Respiratory Research · 2022 · 47 citations · Full text

Medicine, Internal Medicine, Epidemiology +12

Anticoagulant Use and Bleeding Risk in Central European Patients with Idiopathic Pulmonary Fibrosis (IPF) Treated with Antifibrotic Therapy: Real-World Data from EMPIRE

Abigél Margit Kolonics-Farkas, Martina Šterclová, Nesrin Moğulkoç et al. · Drug Safety · 2020 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries

Abigél Margit Kolonics-Farkas, Martina Šterclová, Nesrin Moğulkoç et al. · Frontiers in Medicine · 2021 · 14 citations · Full text

Veterinary Medicine, Health Sciences, Internal Medicine +16

Survival and lung function decline in patients with definite, probable and possible idiopathic pulmonary fibrosis treated with pirfenidone

Ondřej Májek, Jakub Gregor, Nesrin Moğulkoç et al. · PLoS ONE · 2022 · 10 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15